Back to results
Completed

Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes

NCT00737776

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novo Nordisk Investigational Site

Seoul, South Korea

View on ClinicalTrials.gov
Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes — TrialFind